Allergy Diagnostic Market Projected to Gather $10,472.92 Million and Grow at 11.50% CAGR During the 2021-2028 Forecast Period [180-Pages] | Announced by Research Dive
August 22, 2022 09:05 ET
|
Research Dive
New York, USA, Aug. 22, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global allergy diagnostic market is projected to gather a revenue of $10,472.92 million by...
Attralus Receives U.S. FDA Orphan Drug Designation for AT-01 (Iodine (I-124) Evuzamitide), an Investigational Diagnostic for the Management of Transthyretin Amyloidosis
August 08, 2022 07:00 ET
|
Attralus, Inc
SAN FRANCISCO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic...
Global Biohazard Bags Market to Amass a Revenue of $679.1 Million by 2030 and Grow at a CAGR of 6.38% in the 2022-2030 Timeframe [220-Pages] | Exclusive by Research Dive
August 02, 2022 09:02 ET
|
Research Dive
New York, USA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- As per Research Dive’s latest report, the global biohazard bags market is anticipated to rise at a stunning CAGR of 6.38%, thereby garnering a...
Preimplantation Genetic Testing Market Size is projected to reach USD 2.49 Billion by 2030, growing at a CAGR of 9.75%: Straits Research
July 27, 2022 11:00 ET
|
Straits Research
New York, United States, July 27, 2022 (GLOBE NEWSWIRE) -- Preimplantation genetic testing, also known as preimplantation genetic diagnosis, is a procedure for checking for problems in embryos...
Automated Cell Counters Market Size Worth $10.36Bn, Globally, by 2028 Growing at 5.9% CAGR – Exclusive Report by The Insight Partners
July 27, 2022 06:03 ET
|
The Insight Partners
New York, July 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Automated Cell Counters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type,...
Hemex Health and Mylab Discovery Solutions Launch Gazelle™ PathoCatch™ COVID-19 FIA Test
July 06, 2022 08:00 ET
|
Hemex Health
PORTLAND, Ore. and PUNE, India, July 06, 2022 (GLOBE NEWSWIRE) -- Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device...
Positive New Data from Phase 1/2 Trial of AT-01 (Iodine I-124 Evuzamitide) Presented at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
June 14, 2022 11:45 ET
|
Attralus, Inc
AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific changes in amyloid load over time AT-01 detected...
Attralus to Present New AT-01 Data at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
June 03, 2022 08:00 ET
|
Attralus, Inc
Final Phase 1/2 Study Results for AT-01 (Evuzamitide), Attralus's Novel Pan-Amyloid Imaging Agent for the Detection of Systemic Amyloidosis Repeat PET/CT Imaging of a Patient with Systemic Amyloidosis...
Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology
June 02, 2022 16:10 ET
|
Adaptive Biotechnologies
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Data from Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
Hemex Health announces breakthrough measurement capability for clinicians monitoring sickle cell disease therapy
May 08, 2022 06:00 ET
|
Hemex Health
PORTLAND, Ore. and MUMBAI, India, May 08, 2022 (GLOBE NEWSWIRE) -- Hemex Health, a Portland, Oregon-based health-tech startup, announced a significant enhancement to their Gazelle™ Hb Variant test,...